Jump Financial, LLC Allakos Inc. Transaction History

Jump Financial, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.54 - $0.92 $6,190 - $10,545	-11,463 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$1.0 - $1.45 $11,463 - $16,621	11,463 New	11,463 $11,000
Q2 2023 Oct 21, 2024	BUY	$3.6 - $5.25 $25,588 - $37,317	7,108 Added 62.01%	18,571 $80,000
Q2 2023 Aug 07, 2023	BUY	$3.6 - $5.25 $66,855 - $97,497	18,571 New	18,571 $80,000
Q2 2022 Aug 09, 2022	BUY	$2.6 - $6.14 $42,185 - $99,621	16,225 Added 37.67%	59,299 $186,000
Q1 2022 May 12, 2022	BUY	$5.08 - $9.81 $125,343 - $242,051	24,674 Added 134.1%	43,074 $246,000
Q4 2021 Feb 10, 2022	BUY	$8.55 - $111.89 $157,320 - $2.06 Million	18,400 New	18,400 $180,000
Q3 2021 Nov 12, 2021	SELL	$76.53 - $110.43 $1.9 Million - $2.74 Million	-24,817 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$85.37 - $114.1 $2.12 Million - $2.83 Million	24,817 New	24,817 $2.12 Million

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $20.3M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.